成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart Sign in  
Chemical Structure| 26328-04-1 Chemical Structure| 26328-04-1
Chemical Structure| 26328-04-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

{[proInfo.proName]}

CAS No.: 26328-04-1

,{[proInfo.pro_purity]}

Cinepazide Maleate is a maleate salt form of cinepazide which is a vasodilator.

Synonyms: MD-67350

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of Cinepazide Maleate

CAS No. :26328-04-1
Formula : C26H35N3O9
M.W : 533.57
SMILES Code : O=C(N1CCN(CC(N2CCCC2)=O)CC1)C=CC3=CC(OC)=C(OC)C(OC)=C3.O=C(O)/C=C\C(O)=O
Synonyms :
MD-67350
MDL No. :MFCD01320526
InChI Key :XSTJTOKYCAJVMJ-GVTSEVKNSA-N
Pubchem ID :5282458

Safety of Cinepazide Maleate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • Calcium Channel

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01831011 Acute Ischemic Stroke Phase 2 Completed - China, Shanxi ... More >> the Department of Neurology Xi an, Shanxi, China, 710032 Less <<
NCT01851759 Ischemic Stroke Phase 2 Unknown August 2014 China, Shaanxi ... More >> Xijing Hospital Not yet recruiting Xi'an, Shaanxi, China, 710032 Contact: Gang Zhao ?? 02984775361 ?? zhaogang@fmmu.edu.cn Less <<
NCT01946919 - Unknown June 2014 -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.87mL

0.37mL

0.19mL

9.37mL

1.87mL

0.94mL

18.74mL

3.75mL

1.87mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories